These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30978606)

  • 1. A study on structural characterization of degradation products of cangrelor using LC/QTOF/MS/MS and NMR.
    Guvvala V; Chidambaram Subramanian V; Anireddy JS
    J Pharm Biomed Anal; 2019 Jun; 170():327-334. PubMed ID: 30978606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products.
    P J; Ch V; A L; V G M N; Ch N; N S
    J Pharm Biomed Anal; 2017 Mar; 136():148-155. PubMed ID: 28081501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Guo K; Zhang T; Wang Y; Jin B; Ma C
    J Pharm Biomed Anal; 2019 May; 169():196-207. PubMed ID: 30877931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
    Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
    Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
    Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
    J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced degradation studies of lansoprazole using LC-ESI HRMS and
    Shankar G; Borkar RM; Suresh U; Guntuku L; Naidu VGM; Nagesh N; Srinivas R
    J Mass Spectrom; 2017 Jul; 52(7):459-471. PubMed ID: 28544042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
    Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
    J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
    Adhikari S; Tian J; Rustum AM
    J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Lei Y; Jin B; Ma C; Zhang T; Li T
    J Pharm Biomed Anal; 2017 May; 139():221-231. PubMed ID: 28292681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of forced degradation products of pralatrexate injection by LC-PDA and LC-MS.
    Sastry RVRP; Venkatesan CS; Sastry BS; Mahesh K
    J Pharm Biomed Anal; 2016 Nov; 131():400-409. PubMed ID: 27643862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of degradation products of brivaracetam using liquid chromatography quadrupole time-of-flight tandem mass spectrometry: Degradation pathway elucidation.
    Xu K; Ning M; Li W; Dong H; Lu Y; Hang T; Song M
    Rapid Commun Mass Spectrom; 2024 Jan; 38(2):e9651. PubMed ID: 38124167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
    Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
    Kalariya PD; Talluri MV; Patel PN; Srinivas R
    J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural elucidation of major degradation products of milbemycin oxime drug substance using LC-MS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 Aug; 217():114862. PubMed ID: 35662014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced degradation study of racecadotril: Effect of co-solvent, characterization of degradation products by UHPLC-Q-TOF-MS/MS, NMR and cytotoxicity assay.
    Chiguru V; Lingesh A; R S; N S
    J Pharm Biomed Anal; 2016 Sep; 128():9-17. PubMed ID: 27209450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.